Noveome Biotherapeutics: Funding, Investors & Team (Oct 2026)
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking therapies for the regrowth and repair of damaged or inflamed tissues. Originally established as Stemnion, Inc., the company is situated in the bustling center of Pittsburgh near the Southside Works area. Noveome is dedicated to expanding its presence in Allegheny County and contributing to the region's position as a global leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is an innovative biopharmaceutical firm actively engaged in developing a cutting-edge technology that revolutionizes the field of drug development. Dissimilar to conventional drugs which target specific conditions using individual molecules, Noveome's product is a complex combination of biomolecules with potential to effectively treat a broad spectrum of ailments and injuries. Noveome collaborates with renowned research institutions to advance these therapeutic applications.
Noveome Biotherapeutics has raised $27.4M across 2 funding rounds on record, the most recent a Convertible Note of $6.8M announced in Aug 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Noveome Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Noveome Biotherapeutics Funding Rounds
Noveome Biotherapeutics raised $20.7M in a Series E announced in Aug 2023.
3 years later, a Convertible Note of $6.8M was announced in Aug 2026.
Noveome Biotherapeutics Investors
Noveome Biotherapeutics Founders and Leadership Team
Contact details for the Noveome Biotherapeutics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Noveome Biotherapeutics Funding Compared to Other Biotechnology Startups
Noveome Biotherapeutics' latest round of $6.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Noveome Biotherapeutics in Biotechnology and Pittsburgh
Companies Similar to Noveome Biotherapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Noveome Biotherapeutics Funding FAQs
What does Noveome Biotherapeutics do?
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking therapies for the regrowth and repair of damaged or inflamed tissues. Originally established as Stemnion, Inc., the company is situated in the bustling center of Pittsburgh near the Southside Works area. Noveome is dedicated to expanding its presence in Allegheny County and contributing to the region's position as a global leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is an innovative biopharmaceutical firm actively engaged in developing a cutting-edge technology that revolutionizes the field of drug development. Dissimilar to conventional drugs which target specific conditions using individual molecules, Noveome's product is a complex combination of biomolecules with potential to effectively treat a broad spectrum of ailments and injuries. Noveome collaborates with renowned research institutions to advance these therapeutic applications.
How much funding has Noveome Biotherapeutics raised?
Noveome Biotherapeutics has raised $27.4M across 2 rounds on record. The most recent is a Convertible Note of $6.8M announced in Aug 2026.
When did Noveome Biotherapeutics last raise funding?
Noveome Biotherapeutics' most recent funding round on record is a Convertible Note of $6.8M, announced in Aug 2026.
Who has invested in Noveome Biotherapeutics?
Investors on record for Noveome Biotherapeutics include MAK Capital, Government of Pennsylvania.
Who founded Noveome Biotherapeutics?
FundedIQ lists Gretchen Kraemer (Founder) at Noveome Biotherapeutics.
Where is Noveome Biotherapeutics headquartered?
Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania, United States.
How many employees does Noveome Biotherapeutics have?
Noveome Biotherapeutics is in the 11-50 employee band.
When was Noveome Biotherapeutics founded?
Noveome Biotherapeutics was founded in 2000.
How does Noveome Biotherapeutics' funding compare to other Biotechnology startups?
Noveome Biotherapeutics' latest round of $6.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Noveome Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Noveome Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.